OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
IBP Installed Building Products Inc
NRZ New Residential Investment Corp
BOMN Boston Omaha Corp
GLD SPDR® Gold Shares
GIS General Mills Inc
GILD Gilead Sciences Inc
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGN GAMCO Global Gold, Natural Resources & Income Trust
GEF Greif Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Closing Price
$11.65
Day's Change
0.41 (3.65%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.78
Day's Low
11.27
Volume
(Light)
Volume:
662,946

10-day average volume:
1,249,569
662,946

OSUR's position in the Health Care Equipment & Supplies industry

Industry PeersOSURQDELNEOGVIVOCEMI

Summary

Company ProfileOraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well...
Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid...
Go to QDEL summary
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety...
Go to NEOG summary
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic...
Go to VIVO summary
Chembio Diagnostics, Inc. is a provider of point-of-care diagnostic products for the detection and diagnosis of infectious diseases. The Company is primarily focused on expanding its product...
Go to CEMI summary
52-Week Change

VS. INDUSTRY
41.56%
172.50%
9.14%
103.92%
28.13%
Market Cap

VS. INDUSTRY
$804.3M
$7.6B
$3.9B
$765.0M
$107.7M
Beta

VS. INDUSTRY
0.0
0.4
0.5
0.5
2.0
Dividend Yield

VS. INDUSTRY
--
--
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
21.21x
64.58x
16.62x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$158.5M
$1.0B
$426.1M
$253.7M
$29.1M
Profit Margin

VS. INDUSTRY
-9.05%
36.91%
14.24%
18.21%
-76.55%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
--
10.87%
4.81%
--
Revenue Growth (TTM)

VS. INDUSTRY
2.16%
94.96%
2.42%
26.19%
-19.01%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.